{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:23:19Z","timestamp":1789986199358,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["24NSFSC0358"],"award-info":[{"award-number":["24NSFSC0358"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.parkreldis.2025.107973","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:56:22Z","timestamp":1753728982000},"page":"107973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Association of bilirubin with neurodegenerative disorders: A prospective cohort study from UK biobank"],"prefix":"10.1016","volume":"138","author":[{"given":"Yuxi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunshuang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-1151","authenticated-orcid":false,"given":"Huifang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.parkreldis.2025.107973_bib1","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30190-0","article-title":"The burden of neurological diseases in Europe: an analysis for the global burden of disease study 2017","volume":"5","author":"Deuschl","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.parkreldis.2025.107973_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102357","article-title":"Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance","volume":"99","author":"Gadhave","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.parkreldis.2025.107973_bib3","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat. Med."},{"issue":"15","key":"10.1016\/j.parkreldis.2025.107973_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11154515","article-title":"From biomarkers to precision medicine in neurodegenerative diseases: where are we?","volume":"11","author":"Tondo","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.parkreldis.2025.107973_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149472","article-title":"Unraveling the dual role of bilirubin in neurological diseases: a comprehensive exploration of its neuroprotective and neurotoxic effects","volume":"1851","author":"Kaur","year":"2025","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.parkreldis.2025.107973_bib6","first-page":"92","article-title":"Bilirubin and inflammation in neurodegenerative and other neurological diseases","volume":"7","author":"Sri","year":"2020","journal-title":"Neuroimmunol. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.parkreldis.2025.107973_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0303-8467(03)00031-3","article-title":"Serum bilirubin concentration in patients with amyotrophic lateral sclerosis","volume":"105","author":"I\u0142\u017cecka","year":"2003","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"10","key":"10.1016\/j.parkreldis.2025.107973_bib8","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jocn.2011.02.023","article-title":"Serum bilirubin concentrations and multiple sclerosis","volume":"18","author":"Peng","year":"2011","journal-title":"J. Clin. Neurosci. : Off.J. Neurosurg. Soc. Australas."},{"issue":"6","key":"10.1016\/j.parkreldis.2025.107973_bib9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/CM9.0000000000001300","article-title":"Association between serum bilirubin concentration and parkinson's disease: a meta-analysis","volume":"134","author":"Jin","year":"2020","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107973_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12013-014-0402-x","article-title":"Lower serum bilirubin and uric acid concentrations in patients with Parkinson's disease in China","volume":"72","author":"Qin","year":"2015","journal-title":"Cell Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.parkreldis.2025.107973_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107973_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-2797(01)00209-5","article-title":"Prooxidant and antioxidant activities of bilirubin and its metabolic precursor biliverdin: a structure-activity study","volume":"137","author":"Asad","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.parkreldis.2025.107973_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/srep15045","article-title":"Unconjugated Bilirubin exerts pro-apoptotic effect on platelets via p38-MAPK activation","volume":"5","author":"NaveenKumar","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.parkreldis.2025.107973_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3233\/JPD-230357","article-title":"Parkinson's disease is predominantly an environmental disease","volume":"14","author":"Dorsey","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2025.107973_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.parkreldis.2021.10.030","article-title":"Sex differences in the association between nonalcoholic fatty liver disease and Parkinson's disease","volume":"93","author":"Jeong","year":"2021","journal-title":"Park. Relat. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2025.107973_bib16","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1177\/0963689717738258","article-title":"Estrogen-Estrogen receptor \u03b1 signaling facilitates bilirubin metabolism in regenerating liver through regulating cytochrome P450 2A6 expression","volume":"26","author":"Kao","year":"2017","journal-title":"Cell Transplant."},{"issue":"9","key":"10.1016\/j.parkreldis.2025.107973_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10091352","article-title":"Serum bilirubin levels in overweight and Obese individuals: the importance of anti-inflammatory and antioxidant responses","volume":"10","author":"\u017diberna","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.parkreldis.2025.107973_bib18","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.toxrep.2020.10.017","article-title":"Impact of switching to a heat-not-burn tobacco product on CYP1A2 activity","volume":"7","author":"van der Plas","year":"2020","journal-title":"Toxicol. Rep."},{"issue":"7","key":"10.1016\/j.parkreldis.2025.107973_bib19","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0006-2952(01)00568-8","article-title":"Role of cytochrome P450 1A2 in bilirubin degradation studies in Cyp1a2 (-\/-) mutant mice","volume":"61","author":"Zaccaro","year":"2001","journal-title":"Biochem. Pharmacol."},{"issue":"December","key":"10.1016\/j.parkreldis.2025.107973_bib20","first-page":"1","article-title":"Total serum bilirubin levels as mediators of antiatherosclerosis mechanisms with consideration of smoking status","volume":"22","author":"Tani","year":"2024"},{"issue":"20","key":"10.1016\/j.parkreldis.2025.107973_bib21","doi-asserted-by":"crossref","first-page":"e2132","DOI":"10.1212\/WNL.0000000000009437","article-title":"Tobacco smoking and the risk of Parkinson disease: a 65-year follow-up of 30,000 male British doctors","volume":"94","author":"Mappin-Kasirer","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.parkreldis.2025.107973_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuro.2007.11.002","article-title":"Bilirubin injury to neurons: contribution of oxidative stress and rescue by glycoursodeoxycholic acid","volume":"29","author":"Brito","year":"2008","journal-title":"Neurotoxicology"},{"issue":"S5","key":"10.1016\/j.parkreldis.2025.107973_bib23","article-title":"Plasma total bilirubin in patients with Alzheimer's disease: an observational study","volume":"17","author":"Ramdane","year":"2021"},{"key":"10.1016\/j.parkreldis.2025.107973_bib24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3389\/fnins.2020.00859","article-title":"Abnormal serum bilirubin\/albumin concentrations in dementia patients with A\u03b2 deposition and the benefit of intravenous albumin infusion for Alzheimer's disease treatment","volume":"14","author":"Zhong","year":"2020","journal-title":"Front. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2025.107973_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ggi.12659","article-title":"Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients","volume":"15","author":"Hatanaka","year":"2015","journal-title":"Geriatr. Gerontol. Int."},{"key":"10.1016\/j.parkreldis.2025.107973_bib26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.pharmtox.010909.105600","article-title":"Mechanisms of cell protection by heme oxygenase-1","volume":"50","author":"Gozzelino","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.parkreldis.2025.107973_bib27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nbd.2013.09.018","article-title":"The Janus face of the heme oxygenase\/biliverdin reductase system in Alzheimer disease: it's time for reconciliation","volume":"62","author":"Barone","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107973_bib28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2009.11.033","article-title":"Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease","volume":"469","author":"Padurariu","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.parkreldis.2025.107973_bib29","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/mol.104.002832","article-title":"Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties","volume":"66","author":"Kapitulnik","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"8","key":"10.1016\/j.parkreldis.2025.107973_bib30","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1172\/JCI42168","article-title":"Organic anion transporting polypeptide 1a\/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs","volume":"120","author":"van de Steeg","year":"2010","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.parkreldis.2025.107973_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13060834","article-title":"Expression and function of organic anion transporting polypeptides in the human brain: physiological and pharmacological implications","volume":"13","author":"Sch\u00e4fer","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.parkreldis.2025.107973_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12013-015-0717-2","article-title":"Bilirubin and uric acid: two different anti-oxidants in parkinson's disease","volume":"74","author":"Moccia","year":"2016","journal-title":"Cell Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.parkreldis.2025.107973_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32106-w","article-title":"Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the gunn rat","volume":"8","author":"Vianello","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.parkreldis.2025.107973_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073060","article-title":"Iron overload, microbleeding and the role of bilirubin in Alzheimer's disease brain: revisiting the vascular hypothesis","volume":"26","author":"Ficiar\u00e0","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.parkreldis.2025.107973_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0303-8467(03)00031-3","article-title":"Serum bilirubin concentration in patients with amyotrophic lateral sclerosis","volume":"105","author":"I\u0142zecka","year":"2003","journal-title":"Clin. Neurol. Neurosurg."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202500714X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202500714X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:35:58Z","timestamp":1772775358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380202500714X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"alternative-id":["S135380202500714X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107973","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of bilirubin with neurodegenerative disorders: A prospective cohort study from UK biobank","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107973","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107973"}}